{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:33:04Z","timestamp":1792038784469,"version":"4.4.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung cancer remains the most prevalent malignant neoplasm worldwide, with adenocarcinoma being among its most frequent subtypes. The brain is a common metastatic site in patients with lung adenocarcinoma, often associated with poor prognosis, and brain radiotherapy is the standard recommended treatment. However, the occurrence of an extracranial abscopal effect following brain-directed radiotherapy is rare due to the brain\u2019s unique immune microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>We present the case of a 64-year-old Asian male who was admitted with complaints of \u201cright-sided hemiplegia, reduced muscle strength, impaired ambulation, headache, projectile vomiting, and fatigue persisting for five days\u201d. Magnetic Resonance Imaging (MRI) of the brain revealed multiple space-occupying lesions in the bilateral frontal lobes, left cerebellum, and posterior horn of the right lateral ventricle. The patient underwent palliative brain radiotherapy (targeted to the left frontal lobe and right lateral ventricle posterior horn), after which a significant extracranial abscopal effect was observed even before systemic therapy initiation, accompanied by significant improvement in neurological symptoms. Contrast-enhanced Computed Tomography (CT) of the chest demonstrated multiple space-occupying lesions in both lungs (more prominent in the lower lobe of the left lung), along with metastases involving the bilateral mediastinum, left hilar region, and bilateral supraclavicular lymph nodes. Histopathological evaluation of a biopsy obtained from the right supraclavicular lymph node, supported by morphological and immunohistochemical findings, confirmed metastatic lung adenocarcinoma with a PD-L1 tumor proportion score (TPS) \u226550%. Molecular profiling revealed a KRAS G12C mutation, while EGFR, ALK, and ROS1 alterations were absent. In accordance with NCCN guidelines, the patient received monotherapy immunotherapy with a PD-1 antibody. He achieved a sustained partial response both intracranially and extracranially for up to 24 months, with substantial improvement in quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights that an extracranial abscopal effect can occur following brain radiotherapy alone in lung adenocarcinoma patients with brain metastases and PD-L1 TPS \u226550%. For such patients, the combination of palliative brain radiotherapy and PD-1 antibody therapy may represent a safe and effective therapeutic strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1652515","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:34:22Z","timestamp":1765521262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Remarkable response to pembrolizumab in PD-L1 overexpressing (\u2265 50%) NSCLC and extracranial abscopal effect induced by brain radiotherapy: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Yong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020593","article-title":"Treatment of brain metastases of non-small cell lung carcinoma","volume":"22","author":"Rybarczyk-Kasiuchnicz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829451","article-title":"Tumor immune microenvironment and immunotherapy in brain metastasis from non-small cell lung cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S235714","article-title":"Use of programmed death receptor-1 and\/or programmed death ligand 1 inhibitors for the treatment of brain metastasis of lung cancer","volume":"13","author":"Wang","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13048","article-title":"Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review","volume":"10","author":"Lin","year":"2019","journal-title":"Thorac Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3777","article-title":"Abscopal effect after radiosurgery for solitary brain metastasis from non-small cell lung cancer","volume":"10","author":"Hamilton","year":"2018","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat OncologyBiologyPhysics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"OncoImmunology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"108737","DOI":"10.1016\/j.intimp.2022.108737","article-title":"Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model","volume":"108","author":"Ghaffari-Nazari","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74662","article-title":"Abscopal effect in a patient with metastatic melanoma receiving hypofractionated radiation therapy and dual immune checkpoint inhibition: A case report","volume":"16","author":"Rocchetti","year":"2024","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00174","article-title":"Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score \u2265 50","volume":"39","author":"Reck","year":"2021","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2021.02.001","article-title":"Pembrolizumab as first-line palliative therapy in PD-L1 overexpressing (\u2265 50%) NSCLC: real-world results with special focus on PS \u2265 2, brain metastases, and steroids","volume":"22","author":"Frost","year":"2021","journal-title":"Clin Lung Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1652515\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:34:24Z","timestamp":1765521264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1652515\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":16,"alternative-id":["10.3389\/fonc.2025.1652515"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1652515","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"article-number":"1652515"}}